Biology Reference
In-Depth Information
Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith D, Lisziewicz
J, Lori F, Flexner C, Quinn T, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J,
Siliciano RF. 1999. Latent infection of CD4
T cells provides a mechanism for lifelong persis-
tence of HIV-1, even in patients on e¨ective combination therapy. Nat Med 5: 512±517.
Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA, Cocchi F, Carlo DJ,
DeVico AL, Gallo RC. 1999. Spontaneous and antigen-induced production of HIV-inhibitory
beta-chemokines are associated with AIDS-free status. Proc Natl Acad Sci USA 96: 11986±
11991.
Gorny MK, Mascola JR, Israel ZR, VanCott TC, Williams C, Balfe P, Hioe C, Brodine S, Burda
S, Zolla-Pazner S. 1998. A human monoclonal antibody speci®c for the V3 loop of HIV
type 1 clade E cross-reacts with other HIV type 1 clades. AIDS Res Hum Retroviruses 14: 213±
221.
Greenway A, Azad A, McPhee D. 1995. Human immunode®ciency virus type 1 Nef protein inhibits
activation pathways in peripheral blood mononuclear cells and T-cell lines. J Virol 69: 1842±
1850.
Grutzkau A, Kruger-Krasagakes S, Kogel H, Moller A, Lippert U, Henz BM. 1997. Detection of
intracellular interleukin-8 in human blast cells: ¯ow cytometry as a guide for immunoelectron
microscopy. J Histochem Cytochem 45: 935±945.
Harding CV, Unanue ER. 1990. Quantitation of antigen-presenting cell MHC classII/peptide
complexes necessary for T-cell stimulation. Nature 346: 574±576.
Holzer TJ, Heynen CA, Novak RM, Pitrak DL, Dawson GJ. 1993. Frequency of cells positive for
HIV-1 p24 antigen assessed by ¯ow cytometry. AIDS 7: S3±S5.
Husain SR, Leland P, Aggarwal BB, Puri RK. 1996. Transcriptional up-regulation of interleukin 4
receptors by human immunode®ciency virus type 1 tat gene. AIDS Res Hum Retroviruses 20:
1349±1359.
Israel N, Hazan U, Alcami J, Munier A, Arenzana-Seisdedos F, Bachelerie F, Israel A, Virelizier
J-L. 1989. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes,
independently and synergistically with mitogens. J Immunol 143: 3956±3960.
Kaplan D, Smith D. 1999. Enzymatic ampli®cation staining for ¯ow cytometric analysis of cell
surface molecules. Cytometry 40: 81±85.
Kerkau T, Bacik I, Bennink JR, Yewdell JW, Hunig T, Schimpl A, Schubert U. 1997. The human
immunode®ciency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosyn-
thesis of major histocompatibility complex (MHC) class I molecules. J Exp Med 185: 1295±
1305.
Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann
AU, Ho DD. 1998. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is
associated with a CCR5 promoter mutation. Nat Med 4: 350±353.
Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY. 1988. Cytokines alter
production of HIV-1 from primary mononuclear phagocytes. Science 241: 1673±1675.
Kux A, Bertram S, Hufert FJ, Schmitz H, von Laer D. 1996. Antibodies to p24 antigen do not
speci®cally detect HIV-infected lymphocytes in AIDS patients. J Immunol Methods 191: 179±
186.
Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. 1996. HIV-1 Tat pro-
tein promotes chemotaxis and invasive behavior by monocytes. J Immunol 157: 974±977.
Laman JD, Schellenkens MM, Abacioglu YH, Lewis GK, Tersmette M, Foucheier RAM, Lange-
dijk JPM, Claassen E, Boersma WJA. 1992. Variant-speci®c monoclonal and group-speci®c
polyclonal human immunode®ciency virus type 1 neutralizing antibodies raised with synthetic
peptides from the gp120 third variable domain. J Virol 66: 1823±1831.
Loken MR, Herzenberg LA. 1975. Analysis of cell populations with a ¯uorescence activated cell
sorter. Ann NY Acad Sci 254: 163±171.
